leisure time -WSS

leisure time

author：explore 2025-09-06 01:55:19 - browse：53422

WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Merck CEO won’t testify in Senate, citing no expertise in drug prices

Wikipedia

WSS

Insurer loopholes limit power of law against surprise medical bills

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Bird flu reported in person exposed to presumably infected cattle

New clues to why women have higher risk of autoimmune disorders

White House pharmacy plagued with problems, investigation finds

Vertex non

focus

leisure time

leisure time

Supreme Court strikes down use of affirmative action

Florida Supreme Court upholds state's abortion ban

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Bright Health sells Medicare Advantage business to Molina

Harvard scientists, with Google, unveil the most detailed brain map ever

Tori Bowie and the unacceptable rates of Black maternal death

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Jerome Adams on the need for new antivirals for Covid

Overprescribed: High cost isn't America's only drug problem

hotspot

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Medicare drug price negotiation legal challenge met with skepticism

How generative AI ratchets up security threats for health systems

Investment in vaccine development is lagging, report finds

Bernie Sanders is gearing up to subpoena pharma CEOs

Reconstructing family trees of blood cells may help predict disease

focus

Wikipedia

leisure time

Wikipedia